Management of Lymphomas: Consensus Document 2018 by an Indian Expert Group

The clinical course of lymphoma depends on the indolent or aggressive nature of the disease. Hence, the optimal management of lymphoma needs a correct diagnosis and classification as B cell, T-cell or natural killer (NK)/T-cell as well as indolent or high-grade type lymphoma. The current consensus s...

Full description

Saved in:
Bibliographic Details
Published inIndian journal of hematology & blood transfusion Vol. 34; no. 3; pp. 398 - 421
Main Authors Nair, Reena, Kakroo, Abhishek, Bapna, Ajay, Gogia, Ajay, Vora, Amish, Pathak, Anand, Korula, Anu, Chakrapani, Anupam, Doval, Dinesh, Prakash, Gaurav, Biswas, Ghanashyam, Menon, Hari, Bhattacharya, Maitreyee, Chandy, Mammen, Parihar, Mayur, Vamshi Krishna, M., Arora, Neeraj, Gadhyalpatil, Nikhil, Malhotra, Pankaj, Narayanan, Prasad, Nair, Rekha, Basu, Rimpa, Shah, Sandip, Bhave, Saurabh, Bondarde, Shailesh, Bhartiya, Shilpa, Nityanand, Soniya, Gujral, Sumeet, Tilak, T. V. S., Radhakrishnan, Vivek
Format Journal Article
LanguageEnglish
Published New Delhi Springer India 01.07.2018
Springer Nature B.V
Subjects
Blood Transfusion Medicine
Hematology
Human Genetics
Lymphoma
Medicine
Medicine & Public Health
Oncology
Review
Review Article
Management
Common regimens
Lymphoma
Consensus statement
Online AccessGet full text

Cover

More Information
Summary:The clinical course of lymphoma depends on the indolent or aggressive nature of the disease. Hence, the optimal management of lymphoma needs a correct diagnosis and classification as B cell, T-cell or natural killer (NK)/T-cell as well as indolent or high-grade type lymphoma. The current consensus statement, developed by experts in the field across India, is intended to help healthcare professionals manage lymphomas in adults over 18 years of age. However, it should be noted that the information provided may not be appropriate to all patients and individual patient circumstances may dictate alternative approaches. The consensus statement discusses the diagnosis, staging and prognosis applicable to all subtypes of lymphoma, and detailed treatment regimens for specific entities of lymphoma including diffuse large B-cell lymphoma, Hodgkin’s lymphoma, follicular lymphoma, T-cell lymphoma, chronic lymphocytic leukemia/small lymphocytic lymphoma, Burkitt’s lymphoma, and anaplastic large cell lymphoma.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
ISSN:0971-4502
0974-0449
0974-0449
0971-4502
DOI:10.1007/s12288-018-0991-4